Idenix Pharmaceuticals, Inc. (Cambridge, MA, www.idenix.com) has appointed John F. Weidenbruch to the position of executive vice president and general counsel.
Idenix Pharmaceuticals, Inc. (Cambridge, MA, www.idenix.com) has appointed John F. Weidenbruch to the position of executive vice president and general counsel. Before joining Idenix, Weidenbruch served as general counsel at Abraxis BioScience Inc. and in various legal roles at Amgen.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.